KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News
KardiaMobile 6L, which it describes in a press release as the world’s only six lead personal ECG.
Manual QT interval measurement with a smartphone-operated single-lead ECG versus 12-lead ECG: a within-patient diagnostic validation study in primary care
The evolution of cardiac care in the wake of COVID-19
KardiaStation
Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device
Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients
Newsroom - Alivecor
RApid Throughput Screening for Asymptomatic COVID-19 Infection With an Electrocardiogram: A Prospective Observational Study - Mayo Clinic Proceedings: Digital Health
Figure. Measuring the QT Interval in Different Clinical Scenarios
New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients
2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals - Varma - 2021 - Annals of Noninvasive Electrocardiology - Wiley Online Library
RApid Throughput Screening for Asymptomatic COVID-19 Infection With an Electrocardiogram: A Prospective Observational Study - Mayo Clinic Proceedings: Digital Health
Using 12-Lead ECG to Detect Drug-Induced Long QT Interval: The Gold Standard
HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic - Heart Rhythm
